Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» First-ever bio-generic drug doesn’t help Novartis shares
First-ever bio-generic drug doesn’t help Novartis shares
First-ever bio-generic drug doesn’t help Novartis shares
Submitted by
admin
on March 8, 2015 - 10:20am
Source:
Marketwatch
News Tags:
biologics
Novartis
Neupogen
Zarxio
Headline:
First-ever bio-generic drug doesn’t help Novartis shares
Do Not Allow Advertisers to Use My Personal information
